What are the treatment options for constipation in pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Constipation in Pregnant Women

Dietary fiber, polyethylene glycol (PEG), and lactulose are the first-line treatments for constipation in pregnant women, with PEG showing faster relief compared to lactulose. 1, 2

Understanding Constipation in Pregnancy

Constipation affects approximately 20-40% of pregnant women due to several factors:

  • Increased progesterone levels slowing GI motility
  • Physical compression from the growing uterus
  • Iron supplementation (common in prenatal vitamins)
  • Reduced physical activity
  • Inadequate fluid intake
  • Hormonal changes 1, 2

Treatment Algorithm

First-Line Approaches (Non-Pharmacological)

  • Dietary modifications:
    • Increase fiber intake to approximately 30g/day (fruits, vegetables, whole grains, legumes)
    • Ensure adequate fluid intake, particularly water 1
    • Avoid excessive straining during bowel movements
    • Use relaxation techniques when defecating

First-Line Pharmacological Options

  1. Bulk-forming agents:

    • Psyllium husk (6.8-10.8g daily with 8-10 oz fluid)
    • Safe in pregnancy due to minimal systemic absorption 1, 2
    • Take immediately before meals rather than between meals
    • May cause bloating as a side effect
  2. Osmotic laxatives:

    • Polyethylene glycol (PEG) (17g daily mixed with 4-8 oz of liquid)

      • Faster onset of action compared to lactulose 3
      • Less bloating than lactulose
      • FDA pregnancy category C 4
    • Lactulose (15 mL twice daily)

      • Effective but may cause more bloating than PEG 1, 3

Second-Line Options (for refractory cases)

  • Stimulant laxatives (use with caution in second and third trimesters only):
    • Bisacodyl or sodium picosulfate
    • Should be used only short-term or occasionally to avoid dehydration or electrolyte imbalances 5, 6

Important Considerations and Cautions

  • Avoid stimulant laxatives in first trimester due to limited safety data 1, 6

  • Limit duration of osmotic laxatives to avoid electrolyte imbalances 5

  • Monitor for adverse effects:

    • PEG may cause nausea, stomach fullness, cramping, diarrhea, or gas 4
    • Excessive use of PEG may lead to fluid loss and electrolyte imbalances 4
    • Bulk-forming agents may cause bloating and abdominal discomfort 2
  • Contraindications:

    • Do not use PEG if allergic to polyethylene glycol 4
    • Avoid all laxatives if symptoms of bowel obstruction are present (nausea, vomiting, abdominal pain) 4

Duration of Treatment

  • PEG is most effective when used for 1-2 weeks 4
  • Discontinue once regular bowel movements are established
  • For persistent constipation beyond 2 weeks, consult a healthcare provider 4

Follow-up Recommendations

After successful treatment, focus on lifestyle modifications to maintain regular bowel habits:

  • Maintain adequate dietary fiber intake
  • Ensure sufficient fluid intake
  • Engage in regular physical activity as appropriate during pregnancy 4

Remember that constipation in pregnancy is common and typically resolves with appropriate management. The treatment approach should prioritize safety for both mother and fetus while effectively relieving symptoms.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Diarrhea and Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treating constipation during pregnancy.

Canadian family physician Medecin de famille canadien, 2012

Research

[Treatment of Chronic Functional Constipation during Pregnancy and Lactation].

Zeitschrift fur Geburtshilfe und Neonatologie, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.